Français
Search this site:
Symbol
Last
Change
IPN.PA
22.05 €
(+1.59 % )
powered by Euronext©
The Group
Profile & Key figures
Message from the Chairman
Group history
R & D
R & D Homepage
Neurology
Endocrinology
Oncology
Primary care
Medicines
Governance
Board of directors
Executive committee
Board committees
Compensation of corporate officers
Business Development & Alliance Management
Ipsen worldwide
Targeted diseases
Neurology
Endocrinology
Oncology
Hematology
Primary care
Commitments
Vision, mission and values
Environment, health and safety
Ethics and compliance
Support to Patient Organizations
Solidarity
Fondation IPSEN
La Fondation Ipsen at a glance
Colloques, prizes, publications
Neurosciences
Alzheimer’s disease
Endocrinology
Cancer science
Longevity
Vascular
Partnerships
Salk Institute - Nature
Cell Press - Massachusetts General Hospital
Nature Publishing Group
Home
>
Press room
> Publications
Publications
Press releases
Publications
You can sort the publications by year :
All
2005
2006
2007
2008
2009
2010
2011
2012
Registration document 2010
Download
2010 key figures and strategy project
Download
Registration Document 2009
Download
Annual Report 2009
Download
Annual Report 2008
Download
Registration Document 2008
Download
A convergence of approaches for therapeutic research
Download
Creating the future: New challenges in Biology and Medecine - Abstracts
Download
Registration Document 2007
Download
Annual Report 2007
Download
1
2
next ›
last »
Go to
Press room
Investor relations
Careers
Registration Document 2010
Download
Press releases
02 February 2012
Paris (France)
Ipsen’s fourth quarter and full year 2011 sales and other significant developments
Download the press release
Download the presentation
27 January 2012
Paris (France)
Ipsen acknowledges Tanakan® delisting in France
Download
24 January 2012
Paris (France)
Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement
Download